EUVIMEDEUVIMED entdecken
Crossref

HER2 ‐targeting zongertinib shows early activity in untreated advanced HER2 ‐mutant NSCLC

Leah Lawrence

Cancer · 01.08.2026 · 132 (15)

DOI: 10.1002/cncr.70489 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 27.07.2026. Verfasst von Leah Lawrence. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Lawrence, L. (2026). HER2 ‐targeting zongertinib shows early activity in untreated advanced HER2 ‐mutant NSCLC. Cancer, 132(15). https://doi.org/10.1002/cncr.70489

Vancouver

Lawrence L. HER2 ‐targeting zongertinib shows early activity in untreated advanced HER2 ‐mutant NSCLC. Cancer. 2026;132(15). doi:10.1002/cncr.70489

BibTeX
@article{Lawrence2026,
  author = {Lawrence, Leah},
  title = {HER2 ‐targeting zongertinib shows early activity in untreated advanced HER2 ‐mutant NSCLC},
  journal = {Cancer},
  year = {2026},
  volume = {132},
  number = {15},
  doi = {10.1002/cncr.70489}
}
Kostenlos starten →